Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HCFA Medicare DME supplier surety bond proposal has 15% "penal" level with $3 mil. ceiling.

This article was originally published in The Gray Sheet

Executive Summary

MEDICARE DME SURETY BOND PROPOSAL: COMMENTS ON WAIVER IMPLEMENTATION are being sought by the Health Care Financing Administration in a Jan. 20 Federal Register proposed rule. Under the proposal, HCFA would not immediately implement the waiver, citing a lack of time between enactment of the Balanced Budget Act and the Jan. 1, 1998 effective date of the requirement.

You may also be interested in...



DMEPOS payments

Health Care Financing Administration's Oct. 11 final rule governing claim submissions for durable medical equipment, prosthetics, orthotics and supplies becomes effective Dec. 11. Designed to prevent billing fraud, the rule requires DMEPOS suppliers to obtain a surety bond, and to certify with supplier standards. The rule, which HCFA originally proposed in January 1998 (1"The Gray Sheet" Jan. 26, 1998, I&W-4), carries a 60-day comment period

Ipsen CEO Outlines Strategy For Long-Term Success

While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.

UsernamePublicRestriction

Register

OM013133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel